We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
NNN REIT
NNN
$8.87B
| $2.27M | 0.01% |
55,600
+3,400
| +7% | +$151K |
|
|
ALTM
627
DELISTED
Arcadium Lithium plc
ALTM
| $2.27M | 0.01% |
442,210
-2,622,631
| -86% | -$13.4M |
|
628
Paylocity
PCTY
$8.1B
| $2.26M | 0.01% |
11,351
-1,200
| -10% | -$230K |
|
|
ITCI
629
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.26M | 0.01% |
27,100
+800
| +3% | +$65.7K |
|
630
The Ensign Group
ENSG
$10.6B
| $2.25M | 0.01% |
16,967
+4,200
| +33% | +$610K |
|
631
New York Times
NYT
$10.3B
| $2.25M | 0.01% |
43,304
-3,000
| -6% | -$164K |
|
632
Encompass Health
EHC
$12.2B
| $2.25M | 0.01% |
24,353
| – | – |
|
633
Elastic
ESTC
$8.94B
| $2.24M | 0.01% |
22,600
+3,800
| +20% | +$351K |
|
634
Mueller Industries
MLI
$14.7B
| $2.23M | 0.01% |
56,096
-3,400
| -6% | -$138K |
|
|
CNH
635
CNH Industrial
CNH
$16.7B
| $2.23M | 0.01% |
196,500
-25,900
| -12% | -$295K |
|
636
Credo Technology Group
CRDO
$49.6B
| $2.22M | 0.01% |
33,000
+9,000
| +38% | +$447K |
|
637
LKQ Corp
LKQ
$6.38B
| $2.21M | 0.01% |
60,200
-153,636
| -72% | -$5.87M |
|
638
Lattice Semiconductor
LSCC
$18.2B
| $2.21M | 0.01% |
39,000
+3,200
| +9% | +$176K |
|
639
Glaukos
GKOS
$11.2B
| $2.2M | 0.01% |
14,700
+100
| +0.7% | +$13.8K |
|
640
Henry Schein
HSIC
$10B
| $2.2M | 0.01% |
31,800
-3,100
| -9% | -$223K |
|
641
BILL Holdings
BILL
$5.11B
| $2.2M | 0.01% |
25,956
-1,200
| -4% | -$89.5K |
|
642
Tencent Music
TME
$14.2B
| $2.19M | 0.01% |
192,930
+13,294
| +7% | +$158K |
|
643
Onto Innovation
ONTO
$20.6B
| $2.18M | 0.01% |
13,100
| – | – |
|
644
Western Alliance Bancorporation
WAL
$8.92B
| $2.17M | 0.01% |
25,960
+5,200
| +25% | +$457K |
|
645
Eastman Chemical
EMN
$8.43B
| $2.16M | 0.01% |
23,700
-6,200
| -21% | -$636K |
|
646
Planet Fitness
PLNT
$3.71B
| $2.16M | 0.01% |
21,881
-200
| -0.9% | -$18.3K |
|
647
VF Corp
VFC
$5.79B
| $2.16M | 0.01% |
100,500
-7,200
| -7% | -$147K |
|
648
MasTec
MTZ
$23B
| $2.15M | 0.01% |
15,800
-200
| -1% | -$26.8K |
|
649
Morningstar
MORN
$7.76B
| $2.15M | 0.01% |
6,372
+400
| +7% | +$137K |
|
|
CSW
650
CSW Industrials
CSW
$5.59B
| $2.14M | 0.01% |
6,069
+600
| +11% | +$233K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.